Get all your news in one place.
100's of premium titles.
One app.
Start reading
ABC News
ABC News
Health
the Specialist Reporting Team's Leonie Thorne and national medical reporter Sophie Scott

Australia's 'unique' mix of COVID variants a challenge for monoclonal antibody treatments, study finds

A "uniquely Australian" mix of variants will make treating severe COVID-19 more challenging, according to new research, with fewer drugs left in the "cupboard" that are effective against new strains of the virus.

A new paper spearheaded by the Kirby Institute in Sydney looked at 15 COVID-19 variants in circulation in Australia in 2022, and how successful two types of monoclonal antibodies — Evusheld and Sotrovimab — were in offering protection.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.